Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H

被引:144
作者
Kuhn, S [1 ]
Zipfel, PF [1 ]
机构
[1] BERNHARD NOCHT INST TROP MED,DEPT MOL BIOL,D-20359 HAMBURG,GERMANY
关键词
complement factor H; decay acceleration; complement; recombinant expression; factor-H-like protein-1;
D O I
10.1002/eji.1830261017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human factor H-like protein 1 (FHL-1) is composed of seven repetitive elements (short consensus repeats; SCR) that are identical in sequence to the seven N-terminal SCR of complement factor H. We show that the FHL-1 protein has decay acceleration activity in that it can dissociate C3/C5-convertases bound to the surface of sheep red blood cells. The same activity was also determined for factor H. However, compared to FHL-1, factor H was more efficient in decay acceleration, as about 100-fold less protein was required for a 50 % inhibition of activity. The domain required for decay accelerating activity of FHL-1 and factor H was mapped by the use of recombinant fragments. FHL-1 and a series of truncated forms of the protein were expressed in the baculovirus system. Recombinant FHL-1 and all mutants which include SCR 1-4 were functionally active. These four N-terminal SCR are essential and sufficient for activity, as deletion mutants which lack SCR 1 or SCR 4 showed no activity. These results demonstrate that FHL-1 and factor H have identical and overlapping regulatory functions in the complement system and that the domain required for this activity is located in the overlapping region of both proteins within the N-terminal four SCR.
引用
收藏
页码:2383 / 2387
页数:5
相关论文
共 21 条
[1]   LOCALIZATION OF THE COMPLEMENT-COMPONENT-C3B-BINDING SITE AND THE COFACTOR ACTIVITY FOR FACTOR-I IN THE 38KDA TRYPTIC FRAGMENT OF FACTOR-H [J].
ALSENZ, J ;
LAMBRIS, JD ;
SCHULZ, TF ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1984, 224 (02) :389-398
[2]   STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE COMPLEMENT COMPONENT FACTOR-H WITH THE USE OF DIFFERENT ENZYMES AND MONOCLONAL-ANTIBODIES TO FACTOR-H [J].
ALSENZ, J ;
SCHULZ, TF ;
LAMBRIS, JD ;
SIM, RB ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1985, 232 (03) :841-850
[3]   INTERACTION OF BETA-1H GLOBULIN WITH CELL-BOUND C3B - QUANTITATIVE-ANALYSIS OF BINDING AND INFLUENCE OF ALTERNATIVE PATHWAY COMPONENTS ON BINDING [J].
CONRAD, DH ;
CARLO, JR ;
RUDDY, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (06) :1792-1805
[4]  
GORDON DL, 1995, J IMMUNOL, V155, P348
[5]  
HORSTMANN RD, 1985, J IMMUNOL, V134, P1101
[6]   SURFACE-ASSOCIATED HEPARIN INHIBITS ZYMOSAN-INDUCED ACTIVATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY BY AUGMENTING THE REGULATORY ACTION OF THE CONTROL PROTEINS ON PARTICLE-BOUND C3B [J].
KAZATCHKINE, MD ;
FEARON, DT ;
SILBERT, JE ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (05) :1202-1215
[7]  
KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75
[8]  
KRISTENSEN T, 1986, J IMMUNOL, V136, P3407
[9]  
KUHN S, 1995, J IMMUNOL, V155, P5663
[10]  
KUHN S, 1995, GENE, V62, P225